HomeNewscoronavirusCoronavirus Update | India reports 16,103 new COVID-19 cases, 31 fatalities in last 24 hours

Coronavirus Update | India reports 16,103 new COVID-19 cases, 31 fatalities in last 24 hours

The daily positivity rate was recorded at 4.27 per cent while the weekly positivity rate was 3.81 per cent, according to the ministry.

July 03, 2022 / 10:52 IST
Story continues below Advertisement
A patient suffering from COVID-19 (Image: Reuters)
A patient suffering from COVID-19 (Image: Reuters)

India logged 16,103 new coronavirus infections taking the total tally of COVID-19 cases to 4,35,02,429, while the active cases increased to 1,11,711, according to the Union Health Ministry data updated on Sunday.

The death toll climbed to 5,25,199 with 31 new fatalities, the data updated at 8 am stated. The active cases comprise 0.26 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.54 per cent, the ministry said.

Story continues below Advertisement

An increase of 2,143 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. The daily positivity rate was recorded at 4.27 per cent while the weekly positivity rate was 3.81 per cent, according to the ministry.

The number of people who have recuperated from the disease surged to4,28,65,519 while the case fatality rate was recorded at 1.21 per cent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show